Indication
malabsorption
1 clinical trial
1 product
Clinical trial
A Phase 1, Open-label Study of the Absorption, Metabolism, and Excretion of [14C]-Simufilam Following a Single Oral Dose in Healthy Male SubjectsStatus: Completed, Estimated PCD: 2024-03-27
Product
Simufilam